{"id":34979,"date":"2025-06-27T09:28:04","date_gmt":"2025-06-27T15:28:04","guid":{"rendered":"https:\/\/brakkeconsulting.com\/?p=34979"},"modified":"2025-06-27T09:33:46","modified_gmt":"2025-06-27T15:33:46","slug":"this-week-in-animal-health-elancos-parvo-monoclonal-antibody-gets-expanded-approval","status":"publish","type":"post","link":"https:\/\/brakkeconsulting.com\/pt\/this-week-in-animal-health-elancos-parvo-monoclonal-antibody-gets-expanded-approval\/","title":{"rendered":"Esta semana em sa\u00fade animal: o anticorpo monoclonal parvo da Elanco obt\u00e9m aprova\u00e7\u00e3o expandida"},"content":{"rendered":"<p>***********************************<br \/>\n<strong>Brakke Consulting&#039;s <\/strong><br \/>\n<strong>Not\u00edcias e notas sobre sa\u00fade animal de 27 de junho de 2025<br \/>\n<\/strong><em>Copyright \u00a9 Brakke Consulting<br \/>\n<\/em><em>Editor: Lynn Fondon DVM MBA<br \/>\n<\/em>************************************<\/p>\n<p>NAS NOTICIAS:<br \/>\n<u>Not\u00edcias da Brakke Consulting<br \/>\n<\/u>Pesquisa de Brakke<\/p>\n<p><u>Not\u00edcias de Ganhos<br \/>\n<\/u>General Mills<\/p>\n<p><u>Outras not\u00edcias<br \/>\n<\/u>AHV<br \/>\nBem-estar de Bailey<br \/>\nb\u00fafalo azul<br \/>\nChewy<br \/>\nPr\u00e1tica Digital<br \/>\nEdgard &amp; Cooper<br \/>\nElanco<br \/>\nGeneral Mills<br \/>\nColinas<br \/>\nHolista<br \/>\nCasa da Alquimia-Hamet &amp; Amor<br \/>\nJaguar Sa\u00fade Animal<br \/>\nLaborat\u00f3rios Pegasus<br \/>\nProdutos de sa\u00fade animal Qilu<br \/>\nEscriba<br \/>\nCuidado Veterin\u00e1rio Sploot<br \/>\nSincronia<br \/>\nTrivium Vet<br \/>\nVetHelpDirect<br \/>\nVeterin\u00e1riosDigital<br \/>\nVirbac<br \/>\nProdutos WySE<br \/>\nZIVO Bioci\u00eancia<br \/>\nZomedica<\/p>\n<p><strong>*****************************************<br \/>\n<\/strong><strong>Pesquisa de Brakke<\/strong><\/p>\n<p>Muitos curr\u00edculos de candidatos inadequados obstruem seu e-mail? Gastando seu precioso tempo selecionando uma infinidade de candidatos? Deixe o Brakke Search fazer o trabalho bra\u00e7al para voc\u00ea! Utilizamos nossa ampla rede e d\u00e9cadas de experi\u00eancia para apresentar a voc\u00ea uma pequena lista altamente qualificada dos maiores talentos do setor. Atendemos exclusivamente o setor de sa\u00fade e nutri\u00e7\u00e3o animal desde 1986. At\u00e9 realizamos uma avalia\u00e7\u00e3o qualitativa gratuita de adequa\u00e7\u00e3o do candidato para ajudar a orient\u00e1-lo nas entrevistas finais! Saiba mais em nosso site ou entrando em contato com Jeff Santosuosso em jeff@brakkeconsulting.com<\/p>\n<p><a href=\"https:\/\/brakkeconsulting.com\/pt\/our-services\/recruiting\/custom-search-assignments\/\">www.brakkeconsulting.com<\/a><\/p>\n<p><strong>*********************************************<br \/>\n<\/strong><strong>RELEASES DE NOT\u00cdCIAS DE GANHOS<\/strong><\/p>\n<ul>\n<li><strong>General Mills<\/strong>A , Inc. divulgou os resultados do seu ano fiscal encerrado em 25 de maio de 2025. As vendas l\u00edquidas do segmento Pet na Am\u00e9rica do Norte aumentaram 4%, para $2,5 bilh\u00f5es. As vendas l\u00edquidas org\u00e2nicas praticamente igualaram os n\u00edveis do ano anterior. O lucro operacional do segmento aumentou 3%, para $501 milh\u00f5es.<em> (<\/em><a href=\"https:\/\/investors.generalmills.com\/press-releases\/press-release-details\/2025\/General-Mills-Reports-Fiscal-2025-Fourth-quarter-and-Full-year-Results-and-Provides-Fiscal-2026-Outlook\/default.aspx\"><em>comunicado de imprensa da empresa<\/em><\/a><em>)<\/em><\/li>\n<\/ul>\n<p>***********************************<br \/>\n<strong>COMUNICADOS DE NOT\u00cdCIAS DA EMPRESA<\/strong><\/p>\n<ul>\n<li><strong>Elanco Sa\u00fade Animal<\/strong> anunciou que seu Anticorpo Monoclonal para Parvov\u00edrus Canino (CPMA) recebeu aprova\u00e7\u00e3o condicional do USDA para uso em imunidade passiva, a fim de prevenir o parvov\u00edrus em filhotes que foram expostos ao v\u00edrus. A aprova\u00e7\u00e3o original do CPMA era para o tratamento de filhotes com parvov\u00edrus.<em> (<\/em><a href=\"https:\/\/www.dvm360.com\/view\/canine-parvovirus-monoclonal-antibody-receives-conditional-usda-approval-for-passive-immunity\"><em>DVM360<\/em><\/a><em>)<\/em><\/li>\n<li><strong>Virbac SA<\/strong> anunciou a nomea\u00e7\u00e3o de Paul Martingell como diretor executivo do grupo Virbac, com efeito a partir de 1\u00ba de setembro de 2025. Nos \u00faltimos onze anos, ele fez parte do comit\u00ea executivo que supervisionou a fus\u00e3o dos neg\u00f3cios de Consumer Healthcare da Boehringer Ingelheim e da Sanofi. <em>(<\/em><a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/06\/19\/3102022\/0\/en\/VIRBAC-Paul-Martingell-is-appointed-chief-executive-officer-of-Virbac-effective-September-1-2025.html\"><em>globonewswire<\/em><\/a><em>)<\/em><\/li>\n<li><strong>Nutri\u00e7\u00e3o para animais de estima\u00e7\u00e3o da Hill&#039;s<\/strong> lan\u00e7ou uma nova atualiza\u00e7\u00e3o para suas f\u00f3rmulas Science Diet Urinary Hairball Control, adicionando quatro novos sabores em formato de sach\u00ea para ensopado. A Hill&#039;s tamb\u00e9m est\u00e1 adicionando sach\u00eas para ensopado Science Diet \u00e0 sua linha de ra\u00e7\u00e3o para c\u00e3es. <em>(<\/em><a href=\"https:\/\/www.petfoodprocessing.net\/articles\/19392-hills-pet-nutrition-launches-new-urinary-hairball-control-formulas\"><em>Processamento de alimentos para animais de estima\u00e7\u00e3o<\/em><\/a><em>)<\/em><\/li>\n<li>PRN Pharmacal, uma <strong>Laborat\u00f3rios Pegasus<\/strong> A marca anunciou o lan\u00e7amento do Felycin-CA1 (comprimidos de sirolimus de libera\u00e7\u00e3o prolongada) para o tratamento da hipertrofia ventricular em felinos com cardiomiopatia hipertr\u00f3fica subcl\u00ednica. O Felycin-CA1 foi desenvolvido pela <strong>Trivium Vet<\/strong>, que foi adquirida pela PBI-Gordon Companies Inc. (empresa controladora da Pegasus Laboratories) no in\u00edcio deste ano.<em> (<\/em><a href=\"https:\/\/www.dvm360.com\/view\/novel-cardiology-therapy-for-cats-is-launched\"><em>DVM360<\/em><\/a><em>)<\/em><\/li>\n<li><strong>General Mills<\/strong> anunciou dois lan\u00e7amentos dentro do seu segmento Pet na Am\u00e9rica do Norte com iniciativas de <strong>b\u00fafalo azul <\/strong>e <strong>Edgard &amp; Cooper<\/strong>A Blue Buffalo est\u00e1 entrando no mercado de alimentos frescos para animais de estima\u00e7\u00e3o com o lan\u00e7amento nacional de &quot;Love Made Fresh&quot;, projetado para ser uma solu\u00e7\u00e3o fresca independente ou complementar ao seu portf\u00f3lio de alimentos secos para c\u00e3es. A Edgard &amp; Cooper, marca europeia de alimentos premium para animais de estima\u00e7\u00e3o adquirida pela General Mills em 2024, ser\u00e1 lan\u00e7ada nos EUA em julho por meio de uma parceria exclusiva de varejo com a PetSmart.<em> (<\/em><a href=\"https:\/\/investors.generalmills.com\/press-releases\/press-release-details\/2025\/General-Mills-Accelerates-Growth-With-Blue-Buffalo-Expansion-Into-Fresh-and-Edgard--Cooper-U-S--Launch\/default.aspx\"><em>comunicado de imprensa da empresa<\/em><\/a><em>)<\/em><\/li>\n<li><strong>Chewy<\/strong>A , Inc. anunciou o pre\u00e7o de uma oferta p\u00fablica subscrita de 23.952.096 a\u00e7\u00f5es ordin\u00e1rias Classe A, com valor nominal de $0,01 por a\u00e7\u00e3o, pela Buddy Chester Sub LLC (maior acionista da Chewy, uma entidade afiliada a fundos assessorados pela BC Partners) a um pre\u00e7o ao p\u00fablico de $41,95 por a\u00e7\u00e3o. Al\u00e9m disso, simultaneamente ao encerramento da Oferta, a Chewy concordou em comprar da Buddy Chester Sub $100 milh\u00f5es em a\u00e7\u00f5es ordin\u00e1rias Classe A da Chewy a um pre\u00e7o por a\u00e7\u00e3o igual ao pre\u00e7o de compra por a\u00e7\u00e3o a ser pago pelo subscritor na Oferta.<em> (<\/em><a href=\"https:\/\/investor.chewy.com\/news-and-events\/news\/news-details\/2025\/Chewy-Inc--Announces-Pricing-of-Upsized-Offering-of-Class-A-Common-Stock-by-Selling-Stockholder-and-Concurrent-Repurchase\/default.aspx\"><em>comunicado de imprensa da empresa<\/em><\/a><em>)<\/em><\/li>\n<li><strong>Zomedica<\/strong> anunciou a emiss\u00e3o de uma nova patente relacionada ao seu microsc\u00f3pio TRUVIEW para M\u00e9todos e Sistemas de Calibra\u00e7\u00e3o de Imagens em L\u00e2minas. Com a adi\u00e7\u00e3o desta patente recentemente emitida, o portf\u00f3lio de propriedade intelectual da Zomedica agora inclui 77 patentes emitidas nos EUA e 144 patentes internacionais relacionadas aos seus dispositivos terap\u00eauticos e produtos de diagn\u00f3stico.<em> (<\/em><a href=\"https:\/\/www.biospace.com\/press-releases\/zomedica-announces-issuance-of-additional-patent-for-its-truviewr-microscope\"><em>biospace.com<\/em><\/a><em>)<\/em><\/li>\n<li>A FDA aprovou <strong>Produtos de sa\u00fade animal Qilu <\/strong>Cefovecina s\u00f3dica gen\u00e9rica injet\u00e1vel da Zoetis para o tratamento de infec\u00e7\u00f5es de pele em c\u00e3es e gatos. O medicamento cont\u00e9m o mesmo princ\u00edpio ativo do Convenia, da Zoetis. <em>(<\/em><a href=\"https:\/\/www.dvm360.com\/view\/new-generic-drug-for-skin-infections-is-approved-by-the-fda\"><em>DVM360<\/em><\/a><em>)<\/em><\/li>\n<li><strong>AHV<\/strong> (Animal Health Vision) anunciou o lan\u00e7amento nos EUA do StopLac, um produto para controlar o per\u00edodo de seca em vacas leiteiras<em>. (comunicado de imprensa da empresa)<\/em><\/li>\n<li>O Centro de Medicina Veterin\u00e1ria (CVM) da FDA emitiu cartas de advert\u00eancia a tr\u00eas empresas de animais de estima\u00e7\u00e3o acusadas de vender produtos derivados de cannabis n\u00e3o aprovados: <strong>Bailey&#039;s Wellness, Holista, <\/strong>e <strong>Casa da Alquimia-Hamet &amp; Amor<\/strong>As cartas de advert\u00eancia visavam promover produtos de canabidiol (CBD) para uso em animais que a FDA n\u00e3o aprovou como seguros e eficazes para o uso pretendido, de acordo com a Lei Federal de Alimentos, Medicamentos e Cosm\u00e9ticos. Em particular, a ag\u00eancia expressou preocupa\u00e7\u00e3o com a venda de produtos de CBD n\u00e3o aprovados para animais produtores de alimentos e solicitou medidas imediatas para interromper a venda desses produtos. <em>(<\/em><a href=\"https:\/\/www.avma.org\/news\/fda-issues-warning-letters-companies-selling-unapproved-cbd-products\"><em>Comunicado de imprensa da AVMA<\/em><\/a><em>)<\/em><\/li>\n<li><strong>ZIVO Bioci\u00eancia<\/strong>, Inc. anunciou que firmou um relacionamento com uma empresa l\u00edder em sa\u00fade animal para promover os novos compostos de refor\u00e7o imunol\u00f3gico da ZIVO para uso em v\u00e1rios segmentos do mercado av\u00edcola<em>. (<\/em><a href=\"https:\/\/www.businesswire.com\/news\/home\/20250620564330\/en\/ZIVO-Bioscience-and-Leading-Global-Animal-Health-Company-to-Advance-ZIVOs-Immune-Enhancing-Compounds-in-Poultry\"><em>businesswire<\/em><\/a><em>)<\/em><\/li>\n<li><strong>Sincronia<\/strong> anunciou uma parceria com <strong>Cuidado Veterin\u00e1rio Sploot<\/strong> para oferecer o cart\u00e3o de cr\u00e9dito CareCredit da Synchrony como a primeira solu\u00e7\u00e3o de financiamento da Sploot para donos de animais de estima\u00e7\u00e3o. <em>(<\/em><a href=\"https:\/\/www.prnewswire.com\/news-releases\/synchrony-partners-with-sploot-veterinary-care-to-finance-comprehensive-veterinary-services-with-carecredit-302488375.html\"><em>prnewswire<\/em><\/a><em>)<\/em><\/li>\n<li><strong>Escriba<\/strong>A , uma plataforma com tecnologia de IA que transforma as palavras dos veterin\u00e1rios em notas SOAP estruturadas, anunciou o lan\u00e7amento de uma vers\u00e3o gratuita para hospitais veterin\u00e1rios. A vers\u00e3o gratuita inclui registros m\u00e9dicos ilimitados gerados por IA usando os modelos padr\u00e3o do Scribenote, recursos completos de colabora\u00e7\u00e3o em equipe atrav\u00e9s do Modo Equipes e acesso a documenta\u00e7\u00e3o de ajuda de autoatendimento e suporte por chat com tecnologia de IA. Outros recursos Premium continuam fazendo parte do Scribenote Pro. <em>(<\/em><a href=\"https:\/\/www.globenewswire.com\/news-release\/2025\/06\/24\/3104264\/0\/en\/Scribenote-launches-free-veterinary-AI-scribe-as-adoption-surges-across-practices.html\"><em>globonewswire<\/em><\/a><em>)<\/em><\/li>\n<li><strong>Produtos WySE<\/strong> anunciou o lan\u00e7amento da sua multicozinha Total Pet Kitchen (TPK), o primeiro eletrodom\u00e9stico de bancada projetado especificamente para cozinhar e servir ra\u00e7\u00e3o fresca para animais de estima\u00e7\u00e3o usando ingredientes de qualidade humana. O eletrodom\u00e9stico multifuncional combina mistura, cozimento e extrus\u00e3o em um \u00fanico processo simplificado.<em>. (<\/em><a href=\"https:\/\/www.petfoodprocessing.net\/articles\/19403-wyse-products-launches-multicooker-for-diy-fresh-pet-food\"><em>Processamento de alimentos para animais de estima\u00e7\u00e3o<\/em><\/a><em>)<\/em><\/li>\n<li>UE <strong>Jaguar Sa\u00fade Animal <\/strong>anunciou planos para buscar a aprova\u00e7\u00e3o do Comit\u00ea de Medicamentos Veterin\u00e1rios (CVMP) da Ag\u00eancia Europeia de Medicamentos (EMA) para o Canalevia (comprimidos de crofelemer de libera\u00e7\u00e3o prolongada) na Uni\u00e3o Europeia para o tratamento de diarreia generalizada em c\u00e3es. O Canalevia, sob o nome Canalevia-CA1, \u00e9 aprovado condicionalmente pela FDA como medicamento de prescri\u00e7\u00e3o para o tratamento de diarreia induzida por quimioterapia (DIC) em c\u00e3es nos EUA.<em> (<\/em><a href=\"https:\/\/www.cincinnati.com\/press-release\/story\/1800\/jaguar-health-to-pursue-approval-of-canalevia-in-european-union-for-treatment-of-general-diarrhea-in-dogs\/\"><em>com<\/em><\/a><em>)<\/em><\/li>\n<li>Reino Unido <strong>Pr\u00e1tica Digital <\/strong>anunciou sua fus\u00e3o com <strong>VetHelpDirect e VetsDigital<\/strong>, reunindo tr\u00eas equipes de tecnologia especializadas para oferecer uma experi\u00eancia digital mais conectada e completa para cl\u00ednicas veterin\u00e1rias e seus clientes.<em> (comunicado de imprensa da empresa)<\/em><\/li>\n<\/ul>\n<p><strong>*********************************************<br \/>\n<\/strong><strong>RASTREADOR DE PRE\u00c7O DE A\u00c7\u00d5ES DE SA\u00daDE ANIMAL<\/strong><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-34981 size-full\" src=\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2025\/06\/Screenshot-2025-06-26-171913.png\" alt=\"\" width=\"613\" height=\"644\" srcset=\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2025\/06\/Screenshot-2025-06-26-171913.png 613w, https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2025\/06\/Screenshot-2025-06-26-171913-480x504.png 480w\" sizes=\"(min-width: 0px) and (max-width: 480px) 480px, (min-width: 481px) 613px, 100vw\" \/><\/p>\n<p>***********************************<br \/>\n<strong>NOT\u00cdCIAS DE SA\u00daDE ANIMAL<\/strong><\/p>\n<ul>\n<li>EUA \u2013 ESCOLAS DE VETERIN\u00c1RIA A Universidade de Ci\u00eancias da Sa\u00fade Roseman anunciou esta semana que notificou a institui\u00e7\u00e3o credenciadora de educa\u00e7\u00e3o veterin\u00e1ria do pa\u00eds sobre sua inten\u00e7\u00e3o de iniciar o planejamento de um programa veterin\u00e1rio em Nevada. A Roseman, uma institui\u00e7\u00e3o privada sem fins lucrativos, possui dois campi em Nevada e um em Utah. A escola de veterin\u00e1ria ficaria localizada em Henderson, uma cidade ao sul de Las Vegas. Ela faria parcerias com locais externos para oferecer treinamento cl\u00ednico, um acordo conhecido como modelo distribu\u00eddo. <em>(<\/em><a href=\"https:\/\/news.vin.com\/default.aspx?pid=210&amp;Id=12720650&amp;f5=1\"><em>vin.com<\/em><\/a><em>)<\/em><\/li>\n<\/ul>\n<p>************************************<br \/>\n<strong>PONTO DE VISTA DA BRAKKE CONSULTORIA<\/strong><\/p>\n<p>Esta semana, registramos o an\u00fancio da inten\u00e7\u00e3o de estabelecer uma nova escola de veterin\u00e1ria como parte da Universidade Roseman de Ci\u00eancias da Sa\u00fade, em Nevada. Atualmente, temos 34 escolas de veterin\u00e1ria credenciadas nos EUA, com mais 9 escolas (incluindo a Roseman) em processo de abertura. Embora n\u00e3o esteja claro hoje quantos graduados adicionais ingressar\u00e3o na for\u00e7a de trabalho veterin\u00e1ria a cada ano, n\u00e3o h\u00e1 d\u00favida de que haver\u00e1 um n\u00famero significativamente maior de graduados a cada ano, assim que essas 9 escolas forem credenciadas.<\/p>\n<p>H\u00e1 anos se discute acaloradamente se h\u00e1 escassez de veterin\u00e1rios nos EUA, especialmente na \u00e1rea de animais de produ\u00e7\u00e3o. Certamente, a pandemia de COVID-19 em 2020\/21 exacerbou essa escassez, visto que os animais de estima\u00e7\u00e3o receberam muito mais aten\u00e7\u00e3o e a press\u00e3o dos clientes aumentou na maioria das cl\u00ednicas veterin\u00e1rias. Aumentar o n\u00famero de veterin\u00e1rios em atividade tem sido visto como uma forma de aliviar o &quot;burnout&quot; e as press\u00f5es associadas sentidas pelos veterin\u00e1rios (e tamb\u00e9m pelos membros da equipe profissional).<\/p>\n<p>Para compreender melhor essas press\u00f5es e dificuldades enfrentadas pelos profissionais veterin\u00e1rios, recomendo fortemente que voc\u00ea reserve um tempo para analisar os diversos estudos sobre Bem-Estar Veterin\u00e1rio, de autoria do nosso Consultor S\u00eanior, John Volk, da Brakke Consulting. John e seus coautores publicaram diversos estudos com a Merck Animal Health e a AVMA, que s\u00e3o bastante esclarecedores e ilustram os efeitos dos efeitos adversos observados na pr\u00e1tica veterin\u00e1ria nos \u00faltimos anos. Espero sinceramente que os esfor\u00e7os para ampliar a profiss\u00e3o tornem a medicina veterin\u00e1ria um estilo de vida mais atraente e gratificante para todos os envolvidos.<\/p>\n<p><em>Jim Kroman<\/em><\/p>\n<p>***********************************<br \/>\n<strong>SUA VIS\u00c3O<br \/>\n<\/strong>Na semana passada, pedimos que voc\u00ea comparasse a rotatividade de veterin\u00e1rios em cl\u00ednicas veterin\u00e1rias em 2025 com a de 2024. Quase metade dos entrevistados acredita que a rotatividade de veterin\u00e1rios seja praticamente a mesma do ano passado. No entanto, 21% acreditam que seja maior e 14% afirmam que seja muito maior, sugerindo alguma preocupa\u00e7\u00e3o com o aumento da rotatividade. Enquanto isso, 14% acreditam que a rotatividade \u00e9 menor, e apenas 1% acreditam que seja muito menor. Embora alguns percebam uma mudan\u00e7a no rebanho, a maioria acredita que a for\u00e7a de trabalho veterin\u00e1ria na cl\u00ednica est\u00e1 se mantendo est\u00e1vel.<\/p>\n<p><strong>Essa semana<br \/>\n<\/strong>Nossa pergunta desta semana pede sua opini\u00e3o sobre a amplia\u00e7\u00e3o da for\u00e7a de trabalho veterin\u00e1ria, \u00e0 medida que mais graduados ingressam na profiss\u00e3o a cada ano.<\/p>\n<p><a href=\"https:\/\/www.surveymonkey.com\/r\/WQ9B32Y\">Voc\u00ea acredita que a satisfa\u00e7\u00e3o geral dos veterin\u00e1rios aumentar\u00e1, diminuir\u00e1 ou permanecer\u00e1 praticamente a mesma \u00e0 medida que mais dessas novas escolas veterin\u00e1rias forem surgindo?<\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>************************************ Not\u00edcias e notas sobre sa\u00fade animal da Brakke Consulting para 27 de junho de 2025 Copyright \u00a9 Brakke Consulting Editor: Lynn Fondon DVM MBA ************************************ NAS NOT\u00cdCIAS: Not\u00edcias da Brakke Consulting Not\u00edcias sobre lucros da Brakke Search General Mills Outras not\u00edcias AHV Bailey&#039;s Wellness Blue Buffalo Chewy Digital Practice Edgard &amp; Cooper Elanco General Mills Hill&#039;s Holista House of Alchemy-Hamet &amp; Love Jaguar Animal Health Pegasus Laboratories Qilu Animal Health Products Scribenote Sploot Veterinary Care Synchrony TriviumVet VetHelpDirect VetsDigital Virbac WySE Products ZIVO Bioscience Zomedica ***************************************** Brakke Search Muitos curr\u00edculos de candidatos inadequados entupindo seu e-mail? Gastando seu precioso tempo classificando uma variedade infinita de candidatos? Deixe a Brakke Search fazer o trabalho pesado para voc\u00ea! Utilizamos nossa ampla rede e d\u00e9cadas de experi\u00eancia para apresentar a voc\u00ea uma lista restrita e altamente qualificada dos melhores talentos do setor. Atendemos exclusivamente o setor de sa\u00fade e nutri\u00e7\u00e3o animal desde 1986. Realizamos at\u00e9 mesmo uma avalia\u00e7\u00e3o qualitativa gratuita da aptid\u00e3o do candidato para orient\u00e1-lo em entrevistas finais! Saiba mais em nosso site ou entrando em contato com Jeff Santosuosso pelo e-mail jeff@brakkeconsulting.com www.brakkeconsulting.com ********************************************* COMUNICADOS DE IMPRENSA SOBRE OS RESULTADOS A General Mills, Inc. divulgou os resultados do seu ano fiscal encerrado em 25 de maio de 2025. As vendas l\u00edquidas do segmento Pet na Am\u00e9rica do Norte aumentaram 4%, atingindo $2,5 bilh\u00f5es. As vendas l\u00edquidas org\u00e2nicas praticamente igualaram os n\u00edveis do ano anterior. O lucro operacional do segmento aumentou 3%, atingindo $501 milh\u00f5es. (empresa<\/p>\n<div class=\"view-full-post\"><a href=\"https:\/\/brakkeconsulting.com\/pt\/this-week-in-animal-health-elancos-parvo-monoclonal-antibody-gets-expanded-approval\/\" class=\"view-full-post-btn\">Ver postagem completa<\/a><\/div>\n<p>;<\/p>","protected":false},"author":19,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[1],"tags":[],"class_list":["post-34979","post","type-post","status-publish","format-standard","hentry","category-news"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.0 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>News from Brakke Consulting<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/brakkeconsulting.com\/pt\/this-week-in-animal-health-elancos-parvo-monoclonal-antibody-gets-expanded-approval\/\" \/>\n<meta property=\"og:locale\" content=\"pt_PT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"News from Brakke Consulting\" \/>\n<meta property=\"og:description\" content=\"*********************************** Brakke Consulting&#8217;s Animal Health News &amp; Notes for June 27, 2025 Copyright \u00a9 Brakke Consulting Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: Brakke Consulting News Brakke Search Earnings News General Mills Other News AHV Bailey\u2019s Wellness Blue Buffalo Chewy Digital Practice Edgard &amp; Cooper Elanco General Mills Hill\u2019s Holista House of Alchemy-Hamet &amp; Love Jaguar Animal Health Pegasus Laboratories Qilu Animal Health Products Scribenote Sploot Veterinary Care Synchrony TriviumVet VetHelpDirect VetsDigital Virbac WySE Products ZIVO Bioscience Zomedica ***************************************** Brakke Search Too many inappropriate candidate resumes clogging up your email? Spending your precious time sorting through an endless array of candidates? Let Brakke Search do the legwork for you! We use our broad network and decades of experience to present you a highly qualified short list of the industry\u2019s top talent. We\u2019ve been serving the animal health and nutrition industry exclusively since 1986. We even conduct a free qualitative candidate fit assessment to help guide you in final interviews! Find out more at our website or by contacting Jeff Santosuosso at jeff@brakkeconsulting.com www.brakkeconsulting.com ********************************************* EARNINGS NEWS RELEASES General Mills, Inc. reported results for its fiscal year ended May 25, 2025. North America Pet segment net sales were up 4% to $2.5 billion. Organic net sales essentially matched year-ago levels. Segment operating profit increased 3% to $501 million. (companyView Full Post;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/brakkeconsulting.com\/pt\/this-week-in-animal-health-elancos-parvo-monoclonal-antibody-gets-expanded-approval\/\" \/>\n<meta property=\"og:site_name\" content=\"Brakke Consulting Website\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-27T15:28:04+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-27T15:33:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2025\/06\/Screenshot-2025-06-26-171913.png\" \/>\n<meta name=\"author\" content=\"Amanda McDavid\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"Amanda McDavid\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo estimado de leitura\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/this-week-in-animal-health-elancos-parvo-monoclonal-antibody-gets-expanded-approval\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/this-week-in-animal-health-elancos-parvo-monoclonal-antibody-gets-expanded-approval\/\"},\"author\":{\"name\":\"Amanda McDavid\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615\"},\"headline\":\"This Week in Animal Health: Elanco\u2019s Parvo Monoclonal Antibody Gets Expanded Approval\",\"datePublished\":\"2025-06-27T15:28:04+00:00\",\"dateModified\":\"2025-06-27T15:33:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/this-week-in-animal-health-elancos-parvo-monoclonal-antibody-gets-expanded-approval\/\"},\"wordCount\":1541,\"image\":{\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/this-week-in-animal-health-elancos-parvo-monoclonal-antibody-gets-expanded-approval\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2025\/06\/Screenshot-2025-06-26-171913.png\",\"articleSection\":[\"Newsletter\"],\"inLanguage\":\"pt-PT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/this-week-in-animal-health-elancos-parvo-monoclonal-antibody-gets-expanded-approval\/\",\"url\":\"https:\/\/brakkeconsulting.com\/pt\/this-week-in-animal-health-elancos-parvo-monoclonal-antibody-gets-expanded-approval\/\",\"name\":\"News from Brakke Consulting\",\"isPartOf\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/this-week-in-animal-health-elancos-parvo-monoclonal-antibody-gets-expanded-approval\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/this-week-in-animal-health-elancos-parvo-monoclonal-antibody-gets-expanded-approval\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2025\/06\/Screenshot-2025-06-26-171913.png\",\"datePublished\":\"2025-06-27T15:28:04+00:00\",\"dateModified\":\"2025-06-27T15:33:46+00:00\",\"author\":{\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615\"},\"breadcrumb\":{\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/this-week-in-animal-health-elancos-parvo-monoclonal-antibody-gets-expanded-approval\/#breadcrumb\"},\"inLanguage\":\"pt-PT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/brakkeconsulting.com\/pt\/this-week-in-animal-health-elancos-parvo-monoclonal-antibody-gets-expanded-approval\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-PT\",\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/this-week-in-animal-health-elancos-parvo-monoclonal-antibody-gets-expanded-approval\/#primaryimage\",\"url\":\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2025\/06\/Screenshot-2025-06-26-171913.png\",\"contentUrl\":\"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2025\/06\/Screenshot-2025-06-26-171913.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/brakkeconsulting.com\/pt\/this-week-in-animal-health-elancos-parvo-monoclonal-antibody-gets-expanded-approval\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/brakkeconsulting.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"This Week in Animal Health: Elanco\u2019s Parvo Monoclonal Antibody Gets Expanded Approval\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/brakkeconsulting.com\/#website\",\"url\":\"https:\/\/brakkeconsulting.com\/\",\"name\":\"Brakke Consulting Website\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/brakkeconsulting.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-PT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615\",\"name\":\"Amanda McDavid\",\"url\":\"https:\/\/brakkeconsulting.com\/pt\/author\/amanda\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Not\u00edcias da Brakke Consulting","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/brakkeconsulting.com\/pt\/this-week-in-animal-health-elancos-parvo-monoclonal-antibody-gets-expanded-approval\/","og_locale":"pt_PT","og_type":"article","og_title":"News from Brakke Consulting","og_description":"*********************************** Brakke Consulting&#8217;s Animal Health News &amp; Notes for June 27, 2025 Copyright \u00a9 Brakke Consulting Editor: Lynn Fondon DVM MBA ************************************ IN THE NEWS: Brakke Consulting News Brakke Search Earnings News General Mills Other News AHV Bailey\u2019s Wellness Blue Buffalo Chewy Digital Practice Edgard &amp; Cooper Elanco General Mills Hill\u2019s Holista House of Alchemy-Hamet &amp; Love Jaguar Animal Health Pegasus Laboratories Qilu Animal Health Products Scribenote Sploot Veterinary Care Synchrony TriviumVet VetHelpDirect VetsDigital Virbac WySE Products ZIVO Bioscience Zomedica ***************************************** Brakke Search Too many inappropriate candidate resumes clogging up your email? Spending your precious time sorting through an endless array of candidates? Let Brakke Search do the legwork for you! We use our broad network and decades of experience to present you a highly qualified short list of the industry\u2019s top talent. We\u2019ve been serving the animal health and nutrition industry exclusively since 1986. We even conduct a free qualitative candidate fit assessment to help guide you in final interviews! Find out more at our website or by contacting Jeff Santosuosso at jeff@brakkeconsulting.com www.brakkeconsulting.com ********************************************* EARNINGS NEWS RELEASES General Mills, Inc. reported results for its fiscal year ended May 25, 2025. North America Pet segment net sales were up 4% to $2.5 billion. Organic net sales essentially matched year-ago levels. Segment operating profit increased 3% to $501 million. (companyView Full Post;","og_url":"https:\/\/brakkeconsulting.com\/pt\/this-week-in-animal-health-elancos-parvo-monoclonal-antibody-gets-expanded-approval\/","og_site_name":"Brakke Consulting Website","article_published_time":"2025-06-27T15:28:04+00:00","article_modified_time":"2025-06-27T15:33:46+00:00","og_image":[{"url":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2025\/06\/Screenshot-2025-06-26-171913.png","type":"","width":"","height":""}],"author":"Amanda McDavid","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"Amanda McDavid","Tempo estimado de leitura":"7 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/brakkeconsulting.com\/pt\/this-week-in-animal-health-elancos-parvo-monoclonal-antibody-gets-expanded-approval\/#article","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/pt\/this-week-in-animal-health-elancos-parvo-monoclonal-antibody-gets-expanded-approval\/"},"author":{"name":"Amanda McDavid","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615"},"headline":"This Week in Animal Health: Elanco\u2019s Parvo Monoclonal Antibody Gets Expanded Approval","datePublished":"2025-06-27T15:28:04+00:00","dateModified":"2025-06-27T15:33:46+00:00","mainEntityOfPage":{"@id":"https:\/\/brakkeconsulting.com\/pt\/this-week-in-animal-health-elancos-parvo-monoclonal-antibody-gets-expanded-approval\/"},"wordCount":1541,"image":{"@id":"https:\/\/brakkeconsulting.com\/pt\/this-week-in-animal-health-elancos-parvo-monoclonal-antibody-gets-expanded-approval\/#primaryimage"},"thumbnailUrl":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2025\/06\/Screenshot-2025-06-26-171913.png","articleSection":["Newsletter"],"inLanguage":"pt-PT"},{"@type":"WebPage","@id":"https:\/\/brakkeconsulting.com\/pt\/this-week-in-animal-health-elancos-parvo-monoclonal-antibody-gets-expanded-approval\/","url":"https:\/\/brakkeconsulting.com\/pt\/this-week-in-animal-health-elancos-parvo-monoclonal-antibody-gets-expanded-approval\/","name":"Not\u00edcias da Brakke Consulting","isPartOf":{"@id":"https:\/\/brakkeconsulting.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/brakkeconsulting.com\/pt\/this-week-in-animal-health-elancos-parvo-monoclonal-antibody-gets-expanded-approval\/#primaryimage"},"image":{"@id":"https:\/\/brakkeconsulting.com\/pt\/this-week-in-animal-health-elancos-parvo-monoclonal-antibody-gets-expanded-approval\/#primaryimage"},"thumbnailUrl":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2025\/06\/Screenshot-2025-06-26-171913.png","datePublished":"2025-06-27T15:28:04+00:00","dateModified":"2025-06-27T15:33:46+00:00","author":{"@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615"},"breadcrumb":{"@id":"https:\/\/brakkeconsulting.com\/pt\/this-week-in-animal-health-elancos-parvo-monoclonal-antibody-gets-expanded-approval\/#breadcrumb"},"inLanguage":"pt-PT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/brakkeconsulting.com\/pt\/this-week-in-animal-health-elancos-parvo-monoclonal-antibody-gets-expanded-approval\/"]}]},{"@type":"ImageObject","inLanguage":"pt-PT","@id":"https:\/\/brakkeconsulting.com\/pt\/this-week-in-animal-health-elancos-parvo-monoclonal-antibody-gets-expanded-approval\/#primaryimage","url":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2025\/06\/Screenshot-2025-06-26-171913.png","contentUrl":"https:\/\/brakkeconsulting.com\/wp-content\/uploads\/2025\/06\/Screenshot-2025-06-26-171913.png"},{"@type":"BreadcrumbList","@id":"https:\/\/brakkeconsulting.com\/pt\/this-week-in-animal-health-elancos-parvo-monoclonal-antibody-gets-expanded-approval\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/brakkeconsulting.com\/"},{"@type":"ListItem","position":2,"name":"This Week in Animal Health: Elanco\u2019s Parvo Monoclonal Antibody Gets Expanded Approval"}]},{"@type":"WebSite","@id":"https:\/\/brakkeconsulting.com\/#website","url":"https:\/\/brakkeconsulting.com\/","name":"Site da Brakke Consulting","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/brakkeconsulting.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-PT"},{"@type":"Person","@id":"https:\/\/brakkeconsulting.com\/#\/schema\/person\/cbd3330707aa1f20925a2f9d78722615","name":"Amanda McDavid","url":"https:\/\/brakkeconsulting.com\/pt\/author\/amanda\/"}]}},"_links":{"self":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/34979","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/users\/19"}],"replies":[{"embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/comments?post=34979"}],"version-history":[{"count":3,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/34979\/revisions"}],"predecessor-version":[{"id":34989,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/posts\/34979\/revisions\/34989"}],"wp:attachment":[{"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/media?parent=34979"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/categories?post=34979"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/brakkeconsulting.com\/pt\/wp-json\/wp\/v2\/tags?post=34979"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}